Recipharm has acquired OnTarget Chemistry for SEK 15.1 million, expanding its services into preclinical development services. OnTarget, based in Uppsala, Sweden specializes in medicinal chemistry offering synthesis and analytical services.   The preclinical chemistry services allow Recipharm to engage much earlier in customer projects. OnTarget’s synthesis capabilities will enhance the GMP development of APIs in Recipharm’s Italian subsidiary, Edmond Pharma.   Carl-Johan Spak, executive vice pre...